The endothelium: a new target for therapy

Abstract

At one time considered merely a monolayer of cells lining the vascular conduit, the endothelium has emerged recently as an organ with functions as complex as any in the body. A highly active regulatory organ, the endothelium senses and assesses the hemodynamic, humoral, and inflammatory signals to which it is constantly exposed by the blood and responds by secreting factors that affect vessel tone and structure. These interactions are not merely of academic interest. It has been increasingly recognized that endothelial dysfunction plays a pivotal role in the development and progression of atherosclerosis and coronary artery disease.

Keywords

atherosclerosis l-arginine nitric oxide vasodilation

References

Furchgott RF , Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.

Moncada S , Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995; 13: 1319-1330.

Cooke JP , Tsao PS. Endothelium-derived relaxing factor: an overview. In: Sowers JR (ed). Contemporary endocrinology: endocrinology of the vasculature. Totowa NJ: Humana Press, 1996: 3-19.

Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993; 22 (suppl): S1-S4.

Glasser SP , Selwyn AP , Ganz P. Atherosclerosis: risk factors and the vascular endothelium. Am Heart J 1996; 131: 379-384.

Ignarro LJ , Byrns RE , Buga GM , Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61: 866-879.

Palmer RMJ , Ferrige AG , Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.

Palmer RMJ , Ashton DS , Moncada S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 1988; 333: 664-666.

Stamler JS , Mendelsohn ME , Amarante P et al. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res 1989; 65: 789-795.

10.

Radomski MW , Palmer RM , Moncada S. An l-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad USA 1990; 87: 5193-5197.

11.

Cooke JP , Tsao PS. Cytoprotective effects of NO. Circulation 1993; 88: 2451-2454.

12.

Cooke JP , Tsao PS.

Is NO an endogenous antiatherogenic molecule?

Arterioscler Thromb 1994; 14: 653-655.

13.

Tsao P , McEvoy LM , Drexler H , Butcher E , Cooke JP. Exposure to shear stress alters endothelial adhesiveness: role of nitric oxide. Circulation 1995; 92: 3513-3519.

14.

Lüscher TF , Tanner FC , Tschudi MR , Noll G. Endothelial dysfunction in coronary artery disease. Annu Rev Med 1993; 44: 395-418.

15.

Drexler H , Zeiher AM. Endothelial function in human coronary arteries in vivo: focus on hypercholesterolemia. Hypertension 1991; 18 (suppl II): II-90-II-99.

16.

Cooke JP , Dzau VJ. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997; 48: 489-509.

17.

Drexler H , Hayoz D , Münzel T , Just H , Zelis R , Brunner HR. Endothelial function in congestive heart failure. Am Heart J 1993; 126: 761-764.

18.

Celermajer DS , Sorensen KE , Georgakopoulos D et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88: 2149-2155.

19.

Nava E , Lüscher TF. Endothelium-derived vasoactive factors in hyper-tension: nitric oxide and endothelin. J Hypertens 1995; 13 (suppl): S39-S40.

20.

Cooke JP , Tsao PS.

Arginine: a new therapy for atherosclerosis?

Circulation 1997; 95: 311-312.

21.

Harrison DG , Armstrong ML , Freiman PC , Heistad DD. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 1987; 80: 1808-1811.

22.

Clarkson P , Adams MR , Powe AJ et al. Oral l-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest 1996; 97: 1989-1994.

23.

Plotnick GD , Corretti MC , Vogel RA. Transient impairment of endothelium-dependent brachial artery reactivity following a fatty meal. J Am Coll Cardiol 1996; 27: 287A-287A (abstract).

24.

Shimokawa H , Vanhoutte PM. Dietary cod-liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. Circulation 1988; 78: 1421-1430.

25.

Haskell WL , Sims C , Myli J , Bortz WM , St Goar FG , Alderman EL. Coronary artery size and dilating capacity in ultra-distance runners. Circulation 1993; 87: 1076-1082.

26.

Treasure CB , Klein L , Weintraub WS et al. Beneficial effects of cholesterol lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481-487.

27.

Mancini GBJ , Henry GC , Macaya C et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dys-function in patients with coronary artery disease: the TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996; 94: 258-265.

28.

Schroeder JS , Gao SZ , Alderman EL et al. A preliminary study of diltiazem in the prevention of coronary artery disease in heart-trans-plant recipients. N Engl J Med 1993; 328: 164-170.

29.

Reis SE , Gloth ST , Blumenthal RS et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994; 89: 52-60.